Testimonials
Are you considering LACRISERT®? Hear what other LACRISERT® users
have to say:
- Janie is a bookkeeper and a Dry Eye sufferer since 1991. Click on video below to hear about Janie’s improvement of symptoms after using LACRISERT®.
- Susan was a book editor but she had to go on disability due to her severe Dry Eye from Sjögren’s syndrome. Click on video below to learn more about how tolerable her Dry Eye has become since she started LACRISERT®.
Submit Your Own Testimonial
Have you been using LACRISERT® to successfully relieve your Dry Eye symptoms? Your experience with LACRISERT® can help other Dry Eye sufferers who are considering their treatment options.
Complete the form below to share your testimonial:
Indications and Usage
LACRISERT® is indicated in patients with moderate to severe Dry Eye syndromes, including keratoconjunctivitis sicca. LACRISERT® is indicated especially in patients who remain symptomatic after an adequate trial of therapy with artificial tear solutions. LACRISERT® is also indicated for patients with exposure keratitis, decreased corneal sensitivity, and recurrent corneal erosions.
Important Safety Information
LACRISERT® is contraindicated in patients who are hypersensitive to hydroxypropyl cellulose. Instructions for inserting and removing LACRISERT® should be carefully followed. If improperly placed, LACRISERT® may result in corneal abrasion. Because LACRISERT® may cause transient blurred vision, patients should be instructed to exercise caution when driving or operating machinery. Patients should be cautioned against rubbing the eye(s) containing LACRISERT®.
The following adverse reactions have been reported, but were in most instances, mild and temporary: transient blurring of vision, ocular discomfort or irritation, matting or stickiness of eyelashes, photophobia, hypersensitivity, eyelid edema, and hyperemia.
Talk to your doctor if you have side effects that bother you or that do not go away. You are encouraged to report side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088.
